Pelago scores $58M to scale digital clinic for substance use administration

Digital substance use administration platform Pelago, previously Give up Genius, introduced it secured $58 million in Sequence C funding, bringing its whole increase to $151 million. 

Present investor Atomico led the spherical with participation from different persevering with buyers, together with Octopus Ventures, Y Combinator and Kinnevik AB. New buyers GreyMatter Capital and Eight Roads additionally participated. 

Laura Connell, companion at Atomico, will be part of the corporate’s board of administrators. 


Pelago, based in 2015, works with well being plans, employers and particular person members to supply adults and adolescents customized digital substance use care, together with remedy for alcohol, tobacco and opioid use. 

Members connect with a physician-led care group and may obtain complicated situation administration, cognitive behavioral remedy, and academic content material. The corporate additionally offers a hub for medication-assisted remedy and distant monitoring instruments, similar to breathalyzers and urinary take a look at kits, for at-home use. 

Pelago will use the funds to speed up its product roadmap, conduct medical analysis and develop its continuum of care.  

“This funding demonstrates robust investor confidence in our progress trajectory and displays our dominance of the substance use administration area. That trajectory features a tenfold progress in income and eligible lives coated since our Sequence B spherical two years in the past,” Dr. Yusuf Sherwani, Pelago’s CEO and cofounder, advised MobiHealthNews in an electronic mail. 

“This fundraise helps advance our mission to interrupt down limitations to substance use care that works. I’m extremely grateful for the employers and payers that we’ve empowered to handle substance use head-on by delivering specialised remedy and evidence-based care to their members, supported by highly effective outcomes information and validated ROI.” 


The vast majority of direct prices related to substance use problems within the U.S. are incurred primarily among the many working-age inhabitants, in accordance with analysis printed in JAMA Community. Employers and medical health insurance payers might offset these excessive prices by contemplating prevention and remedy methods.  

The digital habit remedy firm rebranded from Give up Genius final yr, two years after it closed a $64 million Sequence B funding spherical. The corporate garnered $11 million in Sequence A funding in 2020.  

There have been a number of different startups with digital instruments for habit. Maybe most notable is Pear Therapeutics, which provided a line of digital therapeutics for substance abuse however filed for chapter in April of final yr. Its belongings have been offered at public sale for $6.05 million a month later.

Bicycle Well being is one other firm within the area, providing digital opioid use dysfunction remedy. 

Bicycle introduced final yr it shaped a partnership with compassionate care supplier Wellpath to offer previously incarcerated people entry to buprenorphine month-to-month injections for opioid use dysfunction by way of the Federal Bureau of Prisons and residential reentry facilities.

Different corporations embrace digital alcohol use dysfunction remedy firm Ria Well being, digital habit remedy platform Workit Well being and digital smoking-cessation firm Carrot. 

Abridge brings generative AI answer to Sutter Well being physicians in California

Brightside Well being secures $33 million in Collection C funding